Annual EBITDA
-$496.63M$74.66M+13.07%
Summary
- Current Value
- As of today, BBIO annual EBITDA is -$496.63M, up +13.07% on
- Historical Performance
- BBIO annual EBITDA is down -7.57% over the past 3 years, down -5.35% over the past 5 years
- All-Time High Comparison
- BBIO annual EBITDA is currently -1039.11% below its historical high of -$43.60M set on
- 3-Year Low Comparison
- BBIO annual EBITDA is +16.24% above its 3-year low of -$592.95M reached on
- Sector Comparison
- BBIO annual EBITDA is higher than 1.76% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$496.63M | +13.1% | -7.6% | -5.3% | -1039.1% | |
| Quarterly EBITDA | -$106.03M | +19.8% | +24.8% | -16.1% | -153.6% | |
| TTM EBITDA | -$472.75M | +26.2% | +6.3% | +6.4% | -1030.7% | |
| Price | $75.41 | +45.5% | +146.6% | +46.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $502.08M | +126.3% | +546.6% | +5986.5% | +100.0% | |
| Annual EPS | -$3.79 | -31.5% | -16.0% | +0.5% | -1124.5% | |
| -$502.06M | +13.0% | -7.2% | -5.8% | -1044.8% | ||
| Annual Net Income | -$732.94M | -34.9% | -51.2% | -45.0% | -1572.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$461.67M | N/A | -7.6% |
| 5Y | -$461.67M | -7.6% | |
| All | -$43.60M | -1039.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$592.95M | +16.2% | |
| 5Y | -$592.95M | +16.2% | |
| All | -$592.95M | +16.2% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$496.63M | +13.1% | |
| -$571.29M | +3.7% | |
| -$592.95M | -28.4% | |
| -$461.67M | +19.1% | |
| -$570.79M | -21.1% |
| Year | Value | Change |
|---|---|---|
| -$471.39M | -77.1% | |
| -$266.24M | -45.0% | |
| -$183.66M | -321.3% | |
| -$43.60M | - |
FAQ
- What is the current annual EBITDA of BBIO?
- As of today, BBIO annual EBITDA is -$496.63M
- What is 1-year change in BBIO annual EBITDA?
- BBIO annual EBITDA is up +13.07% year-over-year
- What is 3-year change in BBIO annual EBITDA?
- BBIO annual EBITDA is down -7.57% over the past 3 years
- How far is BBIO annual EBITDA from its all-time high?
- BBIO annual EBITDA is currently -1039.11% below its historical high of -$43.60M set on December 31, 2017
- How does BBIO annual EBITDA rank versus sector peers?
- BBIO annual EBITDA is higher than 1.76% of companies in Healthcare sector
- When is BBIO next annual earnings release?
- As of today, the next annual earnings release for BBIO has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$106.03M$1.26M-1.20%
Summary
- Current Value
- As of today, BBIO quarterly EBITDA is -$106.03M, down -1.20% on
- Historical Performance
- BBIO quarterly EBITDA is up +19.77% year-over-year, up +24.77% over the past 3 years
- All-Time High Comparison
- BBIO quarterly EBITDA is currently -2085.88% below its historical high of $5.34M set on
- 3-Year Low Comparison
- BBIO quarterly EBITDA is +51.80% above its 3-year low of -$219.97M reached on
- Sector Comparison
- BBIO quarterly EBITDA is higher than 2.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$106.03M | -1.2% | +19.8% | +24.8% | -16.1% | |
| Annual EBITDA | -$496.63M | – | +13.1% | -7.6% | -5.3% | |
| TTM EBITDA | -$472.75M | +5.2% | +26.2% | +6.3% | +6.4% | |
| Price | $75.41 | +15.2% | +45.5% | +146.6% | +46.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $243.68M | +25.3% | +120.4% | +10000.0% | +351.1% | |
| Quarterly EPS | -$0.78 | +7.7% | +18.6% | +20.9% | -18.4% | |
| -$107.08M | -1.1% | +19.8% | +24.9% | -13.9% | ||
| Quarterly Net Income | -$155.89M | +6.4% | +15.2% | +3.0% | -52.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$104.77M | -1.2% | |
| 3Y | $5.34M | -2085.9% | |
| 5Y | $5.34M | -2085.9% | |
| All | $5.34M | -2085.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$134.96M | +21.4% | |
| 3Y | -$219.97M | +51.8% | |
| 5Y | -$219.97M | +51.8% | |
| All | -$219.97M | +51.8% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BBIO?
- As of today, BBIO quarterly EBITDA is -$106.03M
- What is BBIO quarterly EBITDA most recent change?
- BBIO quarterly EBITDA was down -1.20% on June 30, 2026
- What is 1-year change in BBIO quarterly EBITDA?
- BBIO quarterly EBITDA is up +19.77% year-over-year
- How far is BBIO quarterly EBITDA from its all-time high?
- BBIO quarterly EBITDA is currently -2085.88% below its historical high of $5.34M set on March 31, 2024
- How does BBIO quarterly EBITDA rank versus sector peers?
- BBIO quarterly EBITDA is higher than 2.93% of companies in Healthcare sector
- When is BBIO next earnings release?
- The next earnings release for BBIO is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$472.75M$26.13M+5.24%
Summary
- Current Value
- As of today, BBIO TTM EBITDA is -$472.75M, up +5.24% on
- Historical Performance
- BBIO TTM EBITDA is up +26.16% year-over-year, up +6.28% over the past 3 years
- All-Time High Comparison
- BBIO TTM EBITDA is currently -1030.66% below its historical high of -$41.81M set on
- 3-Year Low Comparison
- BBIO TTM EBITDA is +30.39% above its 3-year low of -$679.15M reached on
- Sector Comparison
- BBIO TTM EBITDA is higher than 1.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$472.75M | +5.2% | +26.2% | +6.3% | +6.4% | |
| Annual EBITDA | -$496.63M | – | +13.1% | -7.6% | -5.3% | |
| Quarterly EBITDA | -$106.03M | -1.2% | +19.8% | +24.8% | -16.1% | |
| Price | $75.41 | +15.2% | +45.5% | +146.6% | +46.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $713.07M | +22.9% | +202.4% | +10000.0% | +1036.6% | |
| TTM EPS | -$3.57 | +4.7% | +12.8% | +4.9% | +6.6% | |
| -$477.82M | +5.2% | +26.0% | +6.5% | +6.1% | ||
| TTM Net Income | -$702.02M | +3.8% | +10.6% | -20.2% | -30.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$472.75M | at high | |
| 3Y | -$466.45M | -1.4% | |
| 5Y | -$433.70M | -9.0% | |
| All | -$41.81M | -1030.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$640.23M | N/A | +26.2% |
| 3Y | -$679.15M | +30.4% | |
| 5Y | -$679.15M | +30.4% | |
| All | -$679.15M | +30.4% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BBIO?
- As of today, BBIO TTM EBITDA is -$472.75M
- What is BBIO TTM EBITDA most recent change?
- BBIO TTM EBITDA was up +5.24% on June 30, 2026
- What is 1-year change in BBIO TTM EBITDA?
- BBIO TTM EBITDA is up +26.16% year-over-year
- How far is BBIO TTM EBITDA from its all-time high?
- BBIO TTM EBITDA is currently -1030.66% below its historical high of -$41.81M set on March 31, 2018
- How does BBIO TTM EBITDA rank versus sector peers?
- BBIO TTM EBITDA is higher than 1.80% of companies in Healthcare sector
- When is BBIO next earnings release?
- The next earnings release for BBIO is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BBIO Official Website bridgebio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000174388126000009/0001743881-26-000009-index.htm
- BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
- BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio